Data as of Mar 07
| -0.01 / -0.56%|
The 5 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 1.50. The median estimate represents a +95.53% increase from the last price of 1.79.
The current consensus among 8 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.